Aging is the main cause behind most illnesses that eventually kill us. Your chance of dying doubles every 8 years. By the time you turn 80, half of your peers are dead.
However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice.
But how do we know these treatments will work in humans? We can wait and see if patients receiving these new treatments die later. Or see if onset of age-related disease is postponed. But this is slow. It takes many, many years to know for sure if the treatments work.
Wouldn’t it be great if we had a faster way?
Thanks to the discovery of the epigenetic clock, we can now accurately describe changes to gene regulation caused by aging. By turning this discovery into a blood test, we can measure the exact aging status inside human cells. This will be incredibly useful to researchers involved in aging research. They would know if a treatment works, much earlier than before. So that’s what we’re making: A biomarker for aging which is accurate, affordable and quick.
However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice.
But how do we know these treatments will work in humans? We can wait and see if patients receiving these new treatments die later. Or see if onset of age-related disease is postponed. But this is slow. It takes many, many years to know for sure if the treatments work.
Wouldn’t it be great if we had a faster way?
Thanks to the discovery of the epigenetic clock, we can now accurately describe changes to gene regulation caused by aging. By turning this discovery into a blood test, we can measure the exact aging status inside human cells. This will be incredibly useful to researchers involved in aging research. They would know if a treatment works, much earlier than before. So that’s what we’re making: A biomarker for aging which is accurate, affordable and quick.
Location: Norway, Oslo
Employees: 1-10
Total raised: $1.14M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Skyfall Ve... | skyfall.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.02.2019 | - | $1.14M | - |
Mentions in press and media 1
| Date | Title | Description |
| 24.08.2022 | Age Labs partners with BioAge to decipher healthy longevity using samples from a preeminent Northern European biobank | Age Labs Will use longitudinal samples and clinical data to identify pathways associated with healthy longevity, leading to new biomarkers for early disease detection Unlocking the future of truly personalized and preventive care will requi... |